Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: CD derivatives

May 10, 2021 CD derivatives / Drug delivery / Environmental / Events / Pharma applications

Bridge virtual meeting before the 20th International Cyclodextrin Symposium

As the International Cyclodextrin Symposium (Giardini Naxos, Sicily) has been postponed to 2022 an abridged virtual meeting was organized by

Continue reading

June 5, 2020 CD derivatives / E-ducation

Cyclodextrin-based poly [n]catenanes

Due to the great scientific recognition (Nobel Prize in chemistry in 2016) and the increasing application potentials of mechanically interlocked,

Continue reading

April 16, 2020 CD as API / CD derivatives / Pharma applications

New class of anti-influenza macromolecules based on beta-cyclodextrin

A new class of anti-influenza macromolecules were synthesized based on a cyclodextrin to target conserved viral domains irreversibly. 6’ sialyl-N-acetyllactosamine

Continue reading

January 6, 2020 Pharma applications

Special Issue in Molecules on “Cyclodextrin Chemistry and Toxicology”

Prof. Dr. Marina Isidori, Prof. Dr. Margherita Lavorgna and Prof. Dr. Rosa Iacovino (Università degli Studi della Campania L. Vanvitelli,

Continue reading

November 7, 2018 CD derivatives / Food / Non-pharma applications / Pharma applications

Special Issue of the journal Materials “Cyclodextrin-Based Nanomaterials: Synthesis, Properties, and Applications”

Cyclodextrins (CDs) have become a very common building-block for the design of new smart materials of different nature. This is

Continue reading

Posts pagination

«Previous Posts 1 2

Recent Posts

  • Enhancing Linezolid Solubilization with β-Cyclodextrin Polymer Fractions of Different Molecula Weight
  • Book chapter: Functionalized cyclodextrins in drug delivery
  • β-Cyclodextrin-Complexed 1,8-Cineole Attenuates Motor Deficits and Preserves Tyrosine Hydroxylase Immunoreactivity in a Reserpine-Induced Mouse Model of Parkinsonism
  • Disruption of endosomal transport in cyclodextrin-mediated cytotoxicity
  • New Hungarian Medicine on the Horizon?

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (28)
  • Analysis (75)
  • CD as API (361)
  • CD derivatives (443)
  • Cosmetics and toilettry (55)
  • Diagnosis (15)
  • Drug delivery (832)
  • E-ducation (64)
  • Environmental (144)
  • Events (242)
  • Food (239)
  • Gene delivery (22)
  • Household products (6)
  • In Hungarian (4)
  • Life sciences (46)
  • Non-pharma applications (428)
  • Other industrial use (114)
  • Pharma applications (1,241)
  • Supramolecular systems (45)
  • Uncategorized (175)

Top Posts

  • Enhancing Linezolid Solubilization with β-Cyclodextrin Polymer Fractions of Different Molecula Weight
  • New Hungarian Medicine on the Horizon?
  • Chapter 3: Professor Casu and Cyclodextrins
  • Novel medicament comprising fosaprepitant/SBECD has been approved.
  • Gilead Announces Approval of Veklury® (remdesivir) in Japan for Patients With Severe COVID-19
  • New book on beta-cyclodextrin and its derivatives
  • A Novel In Situ Gelling System of Quercetin/Sulfobutyl-Ether-β-Cyclodextrin Complex-Loaded Chitosan Nanoparticles for the Treatment of Vulvovaginitis
  • Wound dressing based on PVP/PVA nanofibers containing β-cyclodextrin/curcumin complex
  • Oculis aces the Phase 2 clinical trial for OCS-01 treating DME
  • Book chapter: Functionalized cyclodextrins in drug delivery

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,470 other subscribers
Loading Comments...